Friday, 26 January 2018

Apotex CEO Desai resigns: Globe and Mail

(Reuters) - Generic drugmaker Apotex Inc's Chief Executive Jeremy Desai resigned and will be replaced by his predecessor and co-founder Jack Kay, the Globe and Mail reported on Friday.


No comments:

Post a Comment